Back
Alterity Therapeutics 10K Form
Sell
23
ATHE
Alterity Therapeutics
Last Price:
1.08
Seasonality Move:
-3.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATHE News And Ratings
See the #1 stock for the next 7 days that we like better than ATHE
ATHE Financial Statistics
Sales & Book Value
| Annual Sales: | $99.82K |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.78 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.70920 |
|---|---|
| Net Income (TTM): | $-11.16M |
| Gross Margin: | $189.63K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Alterity Therapeutics Earnings Forecast
Key Alterity Therapeutics Financial Ratios
- The Gross Profit Margin over the past 3 years for ATHE is 100.00%.
- The Selling, General & Administrative Expenses for ATHE have been equal to 2,981.41% of Gross Profit Margin.
- The Interest Expense is -0.22% of Operating Income.
- Per Share Earnings over the last 27 years have been positive in 12 years.
Alterity Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ATHE |
| CUSIP: | 02155X |
| Website: | alteritytherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATHE Technical Analysis vs Fundamental Analysis
Sell
23
Alterity Therapeutics (ATHE)
is a Sell
Is Alterity Therapeutics a Buy or a Sell?
-
Alterity Therapeutics stock is rated a Sell
The current Alterity Therapeutics [ATHE] share price is $1.07. The Score for ATHE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.